Literature DB >> 7945177

Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis.

A C Newby1, K M Southgate, M Davies.   

Abstract

We review the importance of extracellular matrix remodelling to the processes of vascular smooth muscle cell migration and proliferation that contribute to morphogenesis of the atherosclerotic plaque. In particular, the role of the matrix degrading metalloproteinase (MMP) family is discussed. This family of neutral, ZN(2+)-requiring enzymes are capable, in principle, of degrading all matrix proteins. Their activity is tightly controlled, however, at the level of synthesis of the inactive zymogens, activation by limited proteolysis and binding to endogenous inhibitor proteins (TIMPs). Direct evidence is presented for the involvement of MMPs in proliferation and outgrowth of vascular smooth muscle cells from explants of rabbit aorta in vitro. This was obtained using two structurally-unrelated inhibitors of MMPs, Ro 31-4724 and Ro 31-7467, both of which inhibited proliferation of cells in a concentration-dependent manner, Ro 31-4724 also inhibited outgrowth. Rabbit aortic smooth muscle cells were further shown to release MMPs, namely a 95 and a 72 kDa gelatinases that were inhibited by Ro 31-4724 and Ro 31-7467. The evidence suggests that degradation of basement membrane by gelatinase is required for proliferation and outgrowth of these cells. The implications of these findings for the pathogenesis and treatment of atherosclerosis are also discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945177     DOI: 10.1007/978-3-642-85660-0_6

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  14 in total

1.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

2.  Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.

Authors:  Mohammad A M Ali; Woo Jung Cho; Bryan Hudson; Zamaneh Kassiri; Henk Granzier; Richard Schulz
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

3.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

4.  Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.

Authors:  Chris Watson; J Paul Spiers; Max Waterstone; Adam Russell-Hallinan; Joseph Gallagher; Kenneth McDonald; Cristin Ryan; John Gilmer; Mark Ledwidge
Journal:  BMC Cardiovasc Disord       Date:  2021-02-12       Impact factor: 2.298

Review 5.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

6.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability.

Authors:  S Björkerud; B Björkerud
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

7.  Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.

Authors:  M P Herman; G K Sukhova; W Kisiel; D Foster; M R Kehry; P Libby; U Schönbeck
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

8.  S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.

Authors:  Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy.

Authors:  Refah Sayın; Mehmet Aslan; Mehmet Emin Kucukoglu; Arda Luleci; Murat Atmaca; Ramazan Esen; Halit Demir
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

10.  Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels.

Authors:  David Wilson; Hamid Massaeli; Grant N Pierce; Peter Zahradka
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.